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Background: Cesarean section is one of the most commonly performed operations in obstetric practice. A multimodal 
approach to post‑cesarean pain management has been shown to be more effective than a unimodal approach, though the 
most effective combination and preferred route of administration are still unknown.
Aim: To compare the effectiveness of rectal diclofenac sodium and intramuscular pentazocine versus intramuscular pentazocine, 
paracetamol, and diclofenac analgesics for pain relief in the first 48 h after cesarean section at Federal Medical Centre, Katsina.
Methods: This was a prospective single‑blind, randomized controlled trial, in which 120 booked women planned for cesarean 
section were recruited and randomly allocated to the study or control group. The study group received 100 mg rectal diclofenac 
sodium 12 h and intramuscular pentazocine 60 mg 6 h, while the control group received intramuscular diclofenac 75 mg 12 h, 
pentazocine 60 mg 6 h, and paracetamol 600 mg 8 h for the first 48 h postoperatively. Pain perception, maternal satisfaction, 
and preferred route of drug administration were compared between the two groups.
Results: The study group had significantly lower mean visual analog scale pain scores and higher maternal satisfaction in 
the first 48 h (P < 0.05). There were no significant differences in the maternal and newborn side effects of the analgesics. 
The rectal route of drug administration was more preferred (P < 0.05).
Conclusion: The study showed that rectal diclofenac sodium and intramuscular pentazocine post‑cesarean section 
analgesic efficacy and maternal satisfaction were superior to that of intramuscular pentazocine, diclofenac, and 
paracetamol.
Key words: Cesarean section; intramuscular pentazocine; postoperative pain relief; rectal diclofenac sodium.
Introduction
Cesarean section (CS) is a very common obstetric surgery 
performed worldwide which has saved the lives of many 
mothers and infants.[1] CS commonly induces moderate to 
severe pain in the immediate 48 h.[2] Pain is an unpleasant 
sensory and emotional experience associated with actual 
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or potential tissue damage or described in terms of such 
damage. Postoperative pain is one of the main postoperative 
adverse outcomes causing distress to patients. Pain 
perception is multifactorial; it begins with tissue damage 
which triggers chains of neuronal activities.[3] Postoperative 
pain after CS consists of two different pain sensations: first, 
the somatic pain from the wound, and second, the visceral 
pain from the uterine contractions. The somatic pain is well 
localized while the visceral pain is a more diffused pain. The 
somatic pain wanes within 1–2 days, while the visceral lasts 
a few days longer.[4] Postoperative pain leads to patient’s 
discomfort and suffering, decreased level of satisfaction, 
prolonged recovery and hospital stay, higher health care 
costs, and increased risk of developing chronic persistent 
pain.[5] The postoperative pain is worst in obstetric patients 
where it interferes with ambulation, breastfeeding, and early 
maternal bonding with the infant. Postoperative pain might 
lead to thromboembolic events due to its limitation of patient 
mobility, uterine sub-involution, and postpartum hemorrhage 
as well as stress on the health care system.[6]
An ideal method of pain relief after CS should be cost-effective, 
safe for the mother, require minimal monitoring, and use of 
drugs that are not secreted into breast milk. The mother 
should not be sedated or hampered by equipment that 
prevents her from moving freely and caring for her baby. Drug 
availability, maternal health conditions, patient preferences, 
and availability of medical expertise and trained support 
staff also play a role in the choice of analgesic method.[7] 
Though the multimodal approach of using an opioid and 
a nonsteroidal anti-inflammatory drug (NSAID) has been 
proposed to give more efficient pain relief and fewer side 
effects, there still remains the challenge of the choice of 
route for administration considering patient’s comfort and 
satisfaction and the medical expertise available. The route 
of administration in most centers depends on the surgeon’s 
preference and departmental protocols. The departmental 
protocol at F.M.C Katsina is the use of a multimodal 
approach of three intramuscular medications comprising 
an opioid (pentazocine) and two non-opioids (diclofenac 
and paracetamol). This multimodal approach involves the 
administration of 18 intramuscular injections in 48 h and 
though provides better relief than the unimodal approach, 
has the limitation of inflicting additional pain and discomfort 
to patients thereby interfering with the aim of postoperative 
pain management, which is geared at making the patient 
more comfortable, early mobilization, infant breastfeeding, 
and early mother-infant bonding. There may also be an 
increased risk of injection site abscess, necrotizing fasciitis, 
and anaphylactic reactions.[8] This is why research for a safer 
and more patient-friendly route of drug administration was 
necessary without compromising analgesic efficacy. The use 
of rectal diclofenac sodium and intramuscular pentazocine 
will reduce the number of intramuscular injections to 8 within 
48 h. It will also reduce the stress on the available limited 
number of trained personnel, as this could be given by junior 
staff with less training or even the patient if need be.
The aim was to compare the efficacy of rectal diclofenac 
sodium combined with intramuscular pentazocine, versus 
the combination of intramuscular diclofenac, paracetamol, 
and pentazocine for post-CS pain relief. The objectives were 
to compare post-CS pain relief of women that received rectal 
diclofenac sodium and intramuscular pentazocine, versus 
intramuscular diclofenac, paracetamol and pentazocine 
combination, to compare patient’s satisfaction with post-CS 
pain relief of women in the two groups, to compare patient’s 
preferred route of drug administration between women in 
the two groups, and to compare their maternal and newborn 
analgesic side effects.
Methods
This study was carried out among consenting pregnant 
women booked for ANC going for CS at Federal Medical 
Centre, Katsina following approval of the hospital research 
ethics committee from September 2018 to January 2019. 
It was a prospective single-blind, randomized controlled 
trial. The sample size was calculated using the formula for 
sample size calculation in randomized controlled trials with 
a quantitative outcome,[9] 10% was added for attrition and a 
sample size of 60 patients was calculated for each group. The 
inclusion criteria were to have 120 consenting parturients 
of ASA (American Society of Anesthesiologists’ classification) 
I and II status scheduled for either emergency or elective 
CS under spinal or general anesthesia during the period of 
study. The exclusion criteria were: allergy to Pentazocine or 
Diclofenac or Paracetamol, peptic ulcer disease or asthma, 
bleeding disorders, psychiatric illness, known sickle cell 
anemia, declined consent, unconscious patients, preexisting 
opioid dependency, unbooked patients for emergency CS.
Eligible pregnant women were recruited consecutively from 
the antenatal clinic, antenatal ward and from labor ward 
for the booked patients going for emergency CS until the 
desired sample size was reached. Patients were assigned 
to one of the two groups using simple randomization. The 
patients were randomly allocated with concealed envelopes 
to either group A or B preoperatively. Two sets of 60 opaque 
envelopes containing pieces of paper labeled as A or B were 
prepared by a research assistant who did not participate in 
data collection. All 120 envelopes were mixed thoroughly 
then numbered 1–120 and placed in a box in the operation 
Obi, et al.: Multimodal vs  multimodal analgesia for pain relief in the first 48h after CS
103Tropical Journal of Obstetrics and Gynaecology / Volume 37 / Issue 1 / January-April 2020
theatre. An envelope was given to each consecutive patient 
who consented and satisfied the inclusion criteria. Group A, 
the study group were given rectal diclofenac sodium and 
intramuscular pentazocine, while Group B, the control 
group were given intramuscular diclofenac, pentazocine, 
and paracetamol as pain relief after CS. Both groups received 
drugs made by the same pharmaceutical company (Bliss GVS 
Pharma Ltd) and standard postoperative care.
The choice of anesthesia, either general or spinal anesthesia 
was determined by the anesthesiologist using anesthetic 
considerations. Intravenous metoclopramide 10 mg and 
intravenous ranitidine 50 mg were given (45–60 min to the 
time of surgery) to patients going for emergency CS. Patients 
for elective CS were given oral metoclopramide 10 mg and 
oral ranitidine 150 mg with a sip of water the morning of 
surgery (2–3 h to the time of surgery) in order to prevent 
aspiration of acidic gastric contents due to full stomach. 
Patients who developed epigastric pain were treated with 
intravenous ranitidine 50 mg. Nausea and vomiting were 
treated with intravenous metoclopramide 10 mg and patients 
with SPO2 (saturated partial pressure of oxygen) <92% were 
given supplemental oxygen.
Pain severity was assessed by the researcher and four 
well-trained research assistants using pain rating scale 
visual analog scale (VAS) at the first 6, 12, 24, and 48 h 
post-operation. The patient’s satisfaction was assessed using 
a Likert scale with pain relief ranging from very satisfied to 
very dissatisfied within 2 h after the last dose of analgesia. 
Rescue analgesia, intramuscular pentazocine 30 mg was 
given if the VAS score was greater than 30 mm. Maternal side 
effects (nausea and vomiting, epigastric pain, drowsiness, anal 
discomfort and diarrhea, injection site soreness) and newborn 
side effects (excessive sleep, poor breast milk suckling, the 
preferred route of drug administration (intramuscular or 
rectal) were assessed by direct questioning of the patient 
using the questionnaire.
The researcher and four trained assistants (resident doctors 
in the department of obstetrics and gynecology), were 
blinded to the drug administered to the patient. To ensure 
that the researcher and research assistants were blinded to 
the patient’s group, the patient operated by or in the team 
of the researcher/research assistants was not assessed by that 
person. The researcher confirmed the surgeon and the team 
which the patient belonged to and then assigned the other 
assistants to do the assessment. The nurses in the post-natal 
ward were not blinded to the study group of the patients 
and the medications to serve. The patients were also aware 
of their study group because of the difference in the route 
of administration. The assessment was done through close 
observation, measurement, and interrogation with the VAS, 
Likert scale on the questionnaire. The patient’s group was 
obtained from the record book after assessment and recorded 
on her questionnaire before data analysis.
Data obtained was entered into a predesigned sheet and 
analyzed using SPSS version 21 (SPSS Inc., Chicago, IL). 
Categorical data were analyzed using the Chi-square test 
or Fisher’s exact test. Mean and standard deviation (SD) 
or median and interquartile range were calculated for 
quantitative variables and the differences between two 
independent groups were compared using student’s t-test 
or Mann-Whitney u test, respectively. The level of statistical 
significance was considered at P < 0.05. Ethical approval was 
obtained from the research ethics committee in the center 
before the commencement of the study.
Results
Table 1 shows the sociodemographic characteristics of 
the two groups comprising their mean age, major tribe, 
predominant religion, occupation, educational status, parity, 
mean gestational age, previous CS, mean weight, and mean 
height. All the characteristics have a P value of more than 
0.05.
Table 2 gives a summary of the operative characteristics 
of the two groups, with the commonest indication for CS 
being cephalopelvic disproportion, a greater percentage of 
the women had emergency CS, over 90% of both groups had 
spinal anesthesia, and the mean duration of surgery had a 
P = 0.003.
The mean VAS scores at 6, 12, 24, and 48 h post-operation 
had P values 0.039, 0.001, <0.001, <0.001, respectively. 
60% of the control group were somewhat satisfied, whereas 
71.0% of the study group were very satisfied with a P value 
of < 0.001 as shown in Table 3.
The maternal and newborn side effects between the two 
groups showed no difference. 96% of the study group and 
51.7% of the control group preferred the rectal route for drug 
administration (P = 0.001) as shown in Table 4.
Discussion
In this study, the difference in the pain perception following 
administration of the analgesics within the first 48 h after 
CS between the two groups was statistically significant as 
shown in Table 3 with statistically significant P values and 
mean VAS scores at 6, 12, 24, and 48 h, respectively. This 
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Table 1: Sociodemographic characteristics













































































































Others*=Ebira, Nupe, Baju, Igala, Idoma. Others**=Tailors, hairdressers, 
students
Table 2: Operative characteristics
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CS: cesarean section; VBAC: vaginal birth after cesarean section; EBL: estimated blood loss;  IQR: interquartile range *statistically significant
shows that the efficacy of intramuscular pentazocine and 
rectal diclofenac sodium for pain relief after CS is superior 
to that of intramuscular pentazocine, diclofenac, and 
paracetamol combination in providing pain relief. Generally, 
there is a paucity of studies in which these two methods of 
multimodal analgesia were compared for pain relief after CS. 
However, other studies have compared the analgesic efficacy 
of the multimodal agents (intramuscular pentazocine-rectal 
diclofenac or intramuscular pentazocine-diclofenac) to a 
unimodal agent (intramuscular pentazocine) for post-CS 
analgesia and the multimodal agents were found to be 
superior to the single agents being compared.[10,11] In one 
of those studies, conducted in Kano, the analgesic efficacy 
of intramuscular diclofenac and pentazocine was compared 
to that of intramuscular pentazocine alone for pain relief 
after CS as measured by the VAS scores. They found that 
the median VAS scores were significantly lower in the 
multimodal analgesia group than in the single analgesia 
group, and they concluded that intramuscular diclofenac 
and pentazocine is more effective than intramuscular 
pentazocine alone in relieving pain after CS.[10] In another 
study at Ile-Ife, the analgesic efficacy of rectal diclofenac 
and intramuscular pentazocine was compared to that of 
intramuscular pentazocine alone, and they found that the 
analgesic efficacy of the rectal diclofenac group was superior 
to that of intramuscular pentazocine alone group.[11] The 
addition of diclofenac suppository to parenteral pentazocine 
in their study accounted for a lower VAS and fewer patients 
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required rescue analgesia compared to the single-agent 
group. This could be explained by the documented effect 
of combining the action of two different analgesics that 
interrupt nociceptive transmission at different levels.
However, the VAS scores of the diclofenac suppository 
group of this study were slightly higher than that of the 
multimodal (intramuscular pentazocine-diclofenac) group in 
another study conducted at Abakiliki, which also compared the 
multimodal analgesia with a unimodal method (intramuscular 
Pentazocine).[12] This slight difference could be as a result of 
the higher average age of the patients used in the study as 
compared to this study that was conducted in north-western 
Nigeria with a younger maternal population who were less 
tolerant to pain. The difference could also be attributed to 
a higher percentage of elective CS in that study unlike in 
this study with a higher percentage of emergency CS and 
cephalopelvic disproportion (CPD) being the commonest 
indication.
Another unimodal study in Nigeria that compared the efficacy 
of diclofenac using two different routes (intramuscular or 
rectal) for post-CS analgesia, found no difference in the pain 
scores and maternal satisfaction in the first 24 h.[13] However, 
the study had a smaller sample size (94) compared to this 
study with a sample size of 120 patients. The blinding method 
used was not clearly stated and it was not also stated if 
the rectal diclofenac given to one group and intramuscular 
diclofenac given to the other, were from the same company. 
The VAS scores and maternal satisfaction may not be 
consistent if patients in each group do not receive medication 
of the same quality.
The rectal diclofenac group in this study had lower 
pain perception post-CS compared to the intramuscular 
triple agent group, as shown from the mean VAS scores 
at the four specified times of assessment despite having 
a higher mean duration of surgery which should have 
predisposed the patients to more intraoperative trauma 
and more post-operation pain.[14] This further shows that 
the rectal diclofenac sodium has very good analgesic 
efficacy.
A very number of patients in this study had rescue analgesia, 
3.3% of the rectal diclofenac group and 11.7% of the 
intramuscular triple agent group. There was no statistically 
significant difference in the findings. Studies by Dahl et al.[15] 
and Munishankar et al.[16] in which 200 mg of rectal diclofenac 
was used daily, also demonstrated fewer requirements for 
rescue analgesia.
Table 3: Maternal pain perception (VAS), maternal satisfaction with pain relief (Likert) and need for rescue analgesia
Variable Group A n=60 Group B n=60 Test P
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Somewhat satisfied
Very satisfied

































VAS: visual analog scale *statistically significant
Table 4: Analgesic side effects and preferred route of drug administration






Soreness at injection site
Newborn side effects
Excessive sleep
Poor breast milk suckling




































Obi, et al.: Multimodal vs  multimodal analgesia for pain relief in the first 48h after CS
106 Tropical Journal of Obstetrics and Gynaecology / Volume 37 / Issue 1 / January-April 2020
The significant difference in maternal satisfaction in the 
two groups obtained in this study means that patient’s 
satisfaction is significantly better in women that received 
a multimodal regimen of rectal diclofenac sodium and 
intramuscular pentazocine than those in the intramuscular 
triple agent group. This finding may be due to the rapid 
systemic absorption and high analgesic efficacy of rectal 
diclofenac sodium. The study in Kano recorded a higher 
maternal satisfaction in the multimodal group than in the 
single-agent group.[10] The Abakiliki study recorded no 
difference in the maternal satisfaction between the unimodal 
and the multimodal group and this was attributed to a higher 
pain tolerance by the study population.[12]
The preferred route of drug administration was compared 
between the study and control group on the choice of the 
rectal or intramuscular route, and there was a significant 
statistical difference (P = <0.001) between the two groups 
with most patients preferring the rectal route over the 
intramuscular route. This is similar to the findings of the study 
at Ile-Ife that compared rectal diclofenac plus intramuscular 
pentazocine with intramuscular pentazocine alone.
There was no significant difference in the maternal 
analgesic side effects (nausea/vomiting, epigastric pain, 
drowsiness, and soreness at the injection site) between 
both groups. None of the patients in either group 
developed diarrhea or anal discomfort. The absence of a 
significant difference was because both groups received 
multimodal analgesics of similar components (opioids and 
NSAIDs). There was no significant difference in the injection 
site soreness despite the multiple injections given in one 
group compared to the other. This may probably be due 
to the analgesic effects of the medications administered, 
which decreased the pain sensation at the injection site, 
and also the injection site soreness was assessed verbally. 
The findings of no difference in maternal side effects are 
similar to the findings in Kano[10] and Ile-Ife.[11] While the 
study at Abakiliki reported reduced side effect profile in the 
pentazocine-diclofenac group compared to the pentazocine 
only group and both groups received medications via 
the intramuscular route. The difference was likely due to 
the combination of opioid and NSAID in the multimodal 
group producing an opioid-sparing effect, which reduced 
the severity of the side effects. There was no statistically 
significant difference in the newborn side effects in the two 
groups due to the fact that the opioid-sparing multimodal 
analgesia limited the amount of opioid transferred into 
breast milk. This is similar to the findings in Kano[10] and 
at Abakiliki.[12]
Conclusion
This study showed that, compared to intramuscular 
pentazocine, diclofenac, and paracetamol combination for 
post-CS analgesia, the intramuscular pentazocine, and rectal 
diclofenac sodium combination have superior analgesic 
efficacy and had more maternal satisfaction. The preferred 
route of administration of post-CS analgesia was the rectal 
route. However, there was no difference in maternal and 
newborn side effects recorded in both groups.
Recommendations
Based on the findings from this study, it is recommended that:
1. The use of rectal diclofenac sodium and intramuscular 
pentazocine analgesics will provide more satisfying and 
efficient pain relief after CS in the department of obstetrics 
and gynecology at FMC Katsina and other centers.
2. More randomized controlled trials should be carried out 
comparing different multimodal analgesia for post-CS 
pain relief for meta-analysis.
3. A prospective multicentered, randomized controlled 
trial comparing the effectiveness and safety of rectal 
diclofenac sodium and intramuscular pentazocine is 
recommended for stronger evidence and generalization.
Limitations
1. Pain perceptions and maternal satisfaction were difficult 
to measure because they are subjective.
2. The newborn side effects assessments were also 
subjective
3. Confounding factors such as maternal anxiety, which 
could have influenced pain perception, could not be 
controlled.
4. The exclusion of unbooked patients for emergency CS 
in whom it is also very important to determine the best 
methods of pain relief.
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